Shares of tech giant Apple (NASDAQ: AAPL) touched a record high on July 6, 2020 and closed trading at $373.85. Apple stock is up by 28% year-to-date, easily beating the broader markets amid the COVID-19 pandemic. Since the start of 2020, Nasdaq (NASDAQ: NDAQ) has gained 13% while the S&P 500 Index and Dow Jones Index have fallen 2% and 8.5% respectively.
Here, we take a look at the company’s key revenue drivers and if Apple stock can continue to beat indexes in the second half of 2020.
Apple still largely dependent on the iPhone
Apple’s flagship product is the iPhone that continues to generate a majority of the company’s revenue. In the March quarter, the iPhone accounted for 50% of company sales, despite a weak demand environment due to the ongoing pandemic.
The dreaded virus first impacted Apple’s supply chain in China as well as consumer demand in the country. This led to Apple withdrawing its guidance for the March quarter as well as for fiscal 2020.
In the last three weeks of the March quarter, the virus spread globally and Apple shutdown its retail stores outside Greater China. This not only hurt Apple’s iPhone sales but also impacted sales of wearables such as the AirPod and Apple Watch. iPhone sales fell 7% year-over-year in the fiscal second quarter of 2020, which ended in March, compared to the 1% growth in overall sales.
Prior to the pandemic, analysts expected Apple to experience robust demand for the iPhone. Consumer demand for its iPhone lineup was solid and its highly anticipated 5G device that was to launch in September 2020 was expected to push sales higher for the next two years.
Apple stock touched a 52-week low of $192.58 and bottomed out towards the end of March.
Apple Services will be a key revenue driver in 2020
Apple’s Services segment has been the company’s fastest-growing business for a while. For the first six months of fiscal 2020, the Services business accounted for 17.4% of total sales, up from 15.7% in the prior-year period. Further, Services sales rose 16.7% in Q1 and Q2 of fiscal 2020, compared to a paltry 2.3% year-over-year increase in iPhone sales.
Apple Services will continue to benefit from its subscription-based offerings that include Apple TV+, Apple Care, Apple Music and Apple Arcade. A subscription-based business model will help the technology behemoth offset cyclicality and generate a predictable stream of cash flows across economic cycles. Apple ended Q1 with 515 million paid subscribers across its businesses and this figure is expected to touch 600 million by the end of CY 2020.
During the recent earnings call, Apple CEO Tim Cook reaffirmed the company’s prior guidance of doubling fiscal 2016 Services revenue by the end of 2020. While the iPhone sales are expected to take a significant hit in the June quarter, a part of this decline will be offset by strong Services sales.
As people are largely staying at home, demand for streaming and gaming services have increased at a rapid pace. These tailwinds, though near-term, may help Apple attract new customers into its ecosystem and this will benefit the company in the upcoming decade.
What next for Apple investors
Similar to most other stocks, it is extremely strange to see Apple trading at record highs in an environment where consumer demand is slowing. Analysts tracking Apple stock expect company sales to fall by 4.2% in the June quarter while overall sales for fiscal 2020 is estimated to increase by 1.4%.
While Apple stock should be on the radar of most investors given its leadership position in multiple businesses, expect short-term volatility to provide buying opportunities in the second half of 2020.
https://www.youtube.com/watch?v=50yUaLybUnA&t=667s China-based internet search firm Baidu Inc. (NASDAQ: BIDU) reported financial results for the second quarter of 2020 on Thursday after the market's close. Earnings exceeded analysts’ expectations, but the
Applied Materials' (NASDAQ: AMAT) earnings and revenue for the third quarter exceeded the market's views. Adjusted EPS of $1.06 and revenue of $4.40 billion in Q3, grew 43% and 23%,
A lot of stocks in the biotech space have skyrocketed this year after their announcements and advances in finding a vaccine or in the treatment of COVID-19. While these companies